What is the typical plasma ceruloplasmin level in an adolescent with Wilson disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Plasma Ceruloplasmin Level in Wilson's Disease in Adolescents

In adolescents with Wilson's disease, plasma ceruloplasmin is typically less than 0.1 g/L (10 mg/dL), though 15-36% of pediatric patients may have levels in the normal range, making it an important but not definitive diagnostic marker. 1

Typical Ceruloplasmin Levels

According to the EASL Clinical Practice Guidelines, the characteristic findings are:

  • Wilson's disease patients: Usually <0.1 g/L (10 mg/dL) 1
  • Normal range: Lower limit varies between 0.15-0.2 g/L depending on laboratory 1
  • Critical caveat: 15-36% of children with Wilson's disease have ceruloplasmin in the normal range 1

Diagnostic Performance and Optimal Cutoffs

Recent high-quality research has refined these thresholds beyond the conventional 0.2 g/L cutoff:

Most accurate cutoff values identified:

  • 0.14 g/L: Provides 100% sensitivity and 100% specificity in genotype-verified patients 2
  • 0.15 g/L: Shows 90.8% sensitivity and 97.7% specificity in large cohorts 3
  • 0.168 g/L (16.8 mg/dL): Demonstrates 95.9% sensitivity and 93.6% specificity specifically in children 4
  • 0.13 g/L: Optimal in a large Chinese cohort with 97.0% sensitivity and 96.1% specificity 5

The conventional cutoff of <0.2 g/L has a false-positive rate of 30.5% and positive predictive value of only 6% when used as a screening test 1, 5.

Leipzig Scoring Framework for Interpretation

The guidelines recommend using ceruloplasmin within a scoring system rather than in isolation 1:

Ceruloplasmin scoring:

  • <0.1 g/L = 2 points
  • 0.1-0.2 g/L = 1 point
  • 0.2 g/L = 0 points

Three-zone probability framework 3:

  • High probability zone: <0.1 g/L (98% WD prevalence)
  • Indeterminate zone: 0.1-0.2 g/L (requires additional testing)
  • Low probability zone: >0.2 g/L (0.5% WD prevalence)

Important Factors Affecting Ceruloplasmin in Adolescents

Age considerations:

  • Ceruloplasmin stabilizes after 6 months of age at 26-33 mg/dL in healthy children 4
  • Adolescence is a common presentation period for Wilson's disease, often with neurological symptoms that may be misdiagnosed as behavioral problems 1

Gender differences:

  • Males have higher ceruloplasmin levels than females in both healthy controls and asymptomatic Wilson's disease patients 4
  • This should be considered when interpreting borderline values

Genotype effects:

  • Patients with R778L homozygotes have lower ceruloplasmin levels 4
  • R778L/R919G genotype combinations show higher ceruloplasmin levels 5

Critical Diagnostic Pitfalls

False negatives (normal ceruloplasmin in Wilson's disease):

  • Hepatic inflammation can elevate ceruloplasmin to normal range (it's an acute phase reactant) 1
  • Estrogen supplementation raises levels 1
  • One series found 12 of 55 Wilson's disease patients had normal ceruloplasmin 1

False positives (low ceruloplasmin without Wilson's disease):

  • Malabsorption syndromes 1
  • Severe end-stage liver disease of any etiology 1
  • Aceruloplasminemia (genetic ceruloplasmin deficiency on chromosome 3) 1
  • Heterozygous carriers (20% have decreased levels) 1
  • 8.1% of healthy children have levels <20 mg/dL 4

Practical Diagnostic Algorithm for Adolescents

When ceruloplasmin <0.1 g/L:

  • High probability of Wilson's disease
  • Proceed with confirmatory testing: 24-hour urinary copper (>1.6 μmol/24h), slit-lamp examination for Kayser-Fleischer rings, liver copper content, ATP7B mutation analysis 1

When ceruloplasmin 0.1-0.2 g/L:

  • Indeterminate zone requiring additional testing
  • Measure 24-hour urinary copper, examine for Kayser-Fleischer rings
  • Consider hepatic copper quantification (>4 μmol/g dry weight diagnostic) 1
  • Genetic testing may be necessary 1

When ceruloplasmin >0.2 g/L:

  • Wilson's disease not excluded, especially in adolescents with hepatic inflammation
  • If clinical suspicion remains high (neurological symptoms, liver disease, family history), proceed with urinary copper and genetic testing 1
  • Consider ceruloplasmin oxidase activity measurement if available (superior to immunologic assays) 1

Monitoring Considerations

Ceruloplasmin alone is insufficient for diagnosis or exclusion of Wilson's disease 1. The diagnosis requires integration of multiple parameters including clinical presentation, Kayser-Fleischer rings, urinary copper excretion, hepatic copper content, and genetic confirmation when needed 1.

For adolescents specifically, a cutoff of 15-16.8 mg/dL (0.15-0.168 g/L) provides optimal diagnostic accuracy while accounting for the age-specific characteristics of this population 4, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.